✦ LIBER ✦

Targeted therapy in inflammatory breast cancer

✍ Scribed by Hideko Yamauchi; Naoto T. Ueno

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 75 KB
Volume: 116
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25171

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel targeted therapies in inflammatory

Novel targeted therapies in inflammatory breast cancer

✍ Massimo Cristofanilli 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

## Abstract Inflammatory breast cancer (IBC) accounts for 1% to 5% of all breast cancer cases. Its aggressive biology is characterized by rapid disease progression and poor prognosis. To improve and standardize therapy for IBC, development of novel therapeutics to molecular targets of IBC is key. T

Adjuvant targeted therapy in early breas

Adjuvant targeted therapy in early breast cancer

✍ John Mackey; Deanna McLeod; Joseph Ragaz; Karen Gelmon; Sunil Verma; Kathleen Pr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views

Systemic therapy of inflammatory breast

Systemic therapy of inflammatory breast cancer from high-dose chemotherapy to targeted therapies : The French experience

✍ Patrice Viens; Carole Tarpin; Henri Roche; François Bertucci 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB 👁 1 views

## Abstract ## BACKGROUND: Aggressiveness of inflammatory breast cancer (IBC) is related to its metastatic potential. The introduction of primary chemotherapy in the multimodality treatment has dramatically changed the prognosis. However, survival remains poor. Since 1995, innovative systemic ther

Combined therapy in breast cancer

✍ V. Shanta; S. Krishnamurthi 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB

Targeting Histone Deacetylase in Cancer

Targeting Histone Deacetylase in Cancer Therapy

✍ Hsiang-Yu Lin; Chang-Shi Chen; Shuan-Pei Lin; Jing-Ru Weng; Ching-Shih Chen 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 8 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Targeting histone deacetylase in cancer

Targeting histone deacetylase in cancer therapy

✍ Hsiang-Yu Lin; Chang-Shi Chen; Shuan-Pei Lin; Jing-Ru Weng; Ching-Shih Chen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB

## Abstract Histone deacetylase (HDAC) is recognized as one of the promising targets for cancer treatment as many HDAC inhibitors have entered clinical trials for both solid and liquid tumors. Nevertheless, the mechanisms underlying the antiproliferative effects of HDAC inhibitors remain elusive. A